Clinical Trials
3 trialsNCT07484022 2026-05-15
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Generate Biomedicines
Phase 1 Recruiting
NCT06405542 2026-03-16
EX-CIPN
University Health Network, Toronto
Phase 1 Active not recruiting
NCT02215083 2017-07-12
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
Eastern Regional Medical Center
Phase 1 Withdrawn